Ramaprasad Srinivasan, M.D., Ph.D.
Urologic Oncology Branch
National Cancer Institute
9000 Rockville Pike
Building 10, Room 1-5940
Bethesda, MD 20892
Dr. Srinivasan is an investigator at the Urologic Oncology Branch, National Cancer Institute (NCI). He obtained his M.D., from the Bangalore Medical College in India and completed his Ph.D., in biomedical sciences at the University of Texas MD Anderson Cancer Center in Houston. He came to NCI in 1999 after completing his Internal Medicine Residency training at the University of Texas Health Science Center-Houston, to pursue a fellowship in Medical Oncology/Hematology. After completing his fellowship, he joined the Urologic Oncology Branch, where he is developing treatment strategies and clinical trials for patients with both hereditary and non-hereditary forms of kidney cancer. He is currently investigating a variety of newer 'targeted' agents in clear cell and papillary kidney cancer, as well as hereditary kidney cancer syndromes such as von Hippel-Lindau, hereditary leiomyomatosis and renal cell cancer and hereditary papillary renal cell cancer (HPRC).
Dr. Srinivasan's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with kidney cancer, leiomyomatosis, or von Hippel-Lindau syndrome. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.